conductor,
most phase2 pd clinical trials fail after stellar phase1 results. that's why i'm skeptical. why?
1. placebo affect. and the phase1 study certainly wasn't a blinded study. one patient secretly taking more meds or altering their med regime
could have easily skewed the results, these were mild/moderate pd'ers.

read the original paper?

i've done research which required statistics to determine if the results of the treatment were sig. different from chance. there is so much variability day to day, hour to hour with pd i am skeptical of such a small study that has so many variables.

if you want to PM me i'll be glad to discuss this further but i believe i have every right to express my skepticism.